<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Overview of infertility</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Overview of infertility</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Overview of infertility</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wendy Kuohung, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Hornstein, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert L Barbieri, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kristen Eckler, MD, FACOG</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 18, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Infertility is a common condition with important psychologic, economic, demographic, and medical implications. Demand for infertility services has grown substantially even though the prevalence of infertility has been stable. This phenomenon likely reflects greater awareness of infertility in the general population, increased access to fertility services (eg, mandated insurance coverage, increase in specialty-trained physicians), and the improving success rates of assisted reproductive technologies. </p><p>This topic review will provide an overview of infertility issues. More detailed discussions of both male and female infertility are found elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>Female-specific content</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/5408.html" rel="external">"Female infertility: Causes"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/5445.html" rel="external">"Female infertility: Evaluation"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/5448.html" rel="external">"Female infertility: Treatments"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Male-specific content</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/7473.html" rel="external">"Causes of male infertility"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/7453.html" rel="external">"Approach to the male with infertility"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/7452.html" rel="external">"Treatments for male infertility"</a>.)</p><p></p><p>In this topic, when discussing study results, we will use the terms "woman/en", "man/en", or "patient(s)" as they are used in the studies presented. We encourage the reader to consider the specific counseling and treatment needs of transgender and gender-expansive individuals.</p><p class="headingAnchor" id="H2"><span class="h1">DESCRIPTION AND RELATED TERMS</span><span class="headingEndMark"> — </span>The American Society for Reproductive Medicine (ASRM) defines infertility as "a disease, condition, or status characterized by any of the following" [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>"The inability to achieve a successful pregnancy based on a patient’s medical, sexual, and reproductive history, age, physical findings, diagnostic testing, or any combination of those factors."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>"The need for medical intervention, including, but not limited to, the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as an individual or with a partner."</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>"In patients having regular, unprotected intercourse and without any known etiology for either partner suggestive of impaired reproductive ability, evaluation should be initiated at 12 months when the female partner is under 35 years of age and at 6 months when the female partner is 35 years of age or older."</p><p>●</p><p>Other terms used when discussing fertility include [<a href="#rid2">2</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fecundity</strong> is clinically defined as the capacity to have a live birth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fecundability</strong> is the probability of achieving a pregnancy in a single menstrual cycle with adequate sperm exposure and no contraception that results in a live birth.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fertility</strong> is the ability to have a clinical pregnancy. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sterility</strong> is a permanent state of infertility.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Time to pregnancy</strong> refers to the length of time, usually measured in months, that it takes a couple to conceive. This parameter is often used in epidemiological studies as a measure of subfecundity [<a href="#rid3">3,4</a>].</p><p></p><p class="headingAnchor" id="H3"><span class="h1">NORMAL FERTILITY</span><span class="headingEndMark"> — </span>Most pregnancies occur during the first six menstrual cycles of attempted conception [<a href="#rid4">4-8</a>]. Additional details of normal fertility are presented in related content. (See  <a class="medical medical_review" href="/d/html/5411.html" rel="external">"Natural fertility and impact of lifestyle factors", section on 'What is normal natural fertility?'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">PREVALENCE AND INFLUENCING FACTORS</span><span class="headingEndMark"> — </span>Based on global data collected between 1990 and 2021, the World Health Organization (WHO) estimates that approximately 1 in 6 adults has experienced infertility at least once in their life [<a href="#rid9">9</a>]. Prevalence estimates were 17.8 percent for adults in high-income countries and 16.5 percent for adults in low- and middle-income countries. Challenges to obtaining representative data include that infertility prevalence varies based on the definition used and study variables included, such as time/period, geographic region, and patient demographic factors. </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of increasing female age</strong> – Infertility prevalence generally rises with increasing female age. Analysis of data from the 2016 Global Burden of Disease Study reported females aged 20 to 24 years had the lowest rates of infertility (approximately 3 percent) while those aged 35 to 39 years had the highest rates (approximately 5.5 percent) [<a href="#rid10">10</a>]. Age-specific contributors include declining ovarian reserve and accrued impact of gynecologic disease, medical comorbidities, and infection, among others. (See  <a class="medical medical_review" href="/d/html/111561.html" rel="external">"Evaluation and management of infertility in females of advancing age"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of race/ethnicity</strong> –<strong> </strong>While race/ethnicity may impact the prevalence of infertility [<a href="#rid11">11</a>], this association likely reflects underlying confounders, such as socioeconomic disadvantage, rather than a true relationship [<a href="#rid12">12</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Impact of nulliparity </strong>–<strong> </strong>For females, nulliparous individuals are more likely to experience infertility than those with a prior pregnancy, across all age groups. In the analysis of data from the US National Survey of Family Growth, nulliparous individuals as a group had more than twice the prevalence of infertility compared with parous individuals (13 versus 6 percent) [<a href="#rid11">11</a>]. Nulliparous individuals aged 35 to 39 years had a nearly fourfold increased prevalence of infertility compared with their parous counterparts (27.2 versus 7 percent).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Access to reproductive health services </strong>– The ability to access reproductive health services is associated with reduced prevalence of infertility, likely through improved screening and treating of gynecologic disease and infection [<a href="#rid11">11</a>]. This finding has significant implications for public policy.</p><p></p><p class="headingAnchor" id="H6"><span class="h1">CAUSES OF INFERTILITY</span><span class="headingEndMark"> — </span>The World Health Organization (WHO) task force on Diagnosis and Treatment of Infertility performed a study of 8500 infertile couples and utilized standard diagnostic criteria to determine the medical conditions contributing to infertility [<a href="#rid13">13</a>]. In developed countries, female factor infertility was reported in 37 percent of infertile couples, male factor infertility in 8 percent, and both male and female factor infertility in 35 percent. Five percent of couples had unexplained infertility and 15 percent became pregnant during the study. This study illustrates that infertility should not be assumed to result primarily from disorders in the female partner.</p><p>Some causes of infertility are easily identifiable, such as azoospermia (no sperm cells in the ejaculate), longstanding amenorrhea, or bilateral tubal obstruction. However, the situation is less clear in most couples: the sperm may be reduced in number, but are not absent; there may be oligomenorrhea with some ovulatory cycles; the woman may have partial tubal obstruction; or a menstrual history may suggest intermittent ovulation. It is often difficult to weigh or prioritize these findings when counseling infertile couples or planning treatment programs.</p><p>Adding to the complexity of the situation, there are few data regarding the predictive validity of these tests despite their widespread use. Thus, short of the absolute infertility factors mentioned (eg, azoospermia or bilateral tubal obstruction), an abnormal test result cannot be said to be the cause of infertility in a particular couple.</p><p>The uncertain causal relationship between an abnormality on infertility testing and the actual cause of infertility makes it difficult to estimate the relative frequency of the causes of infertility. Nevertheless, it is instructive to estimate the frequency with which various factors are found in association with infertility as a rough proxy for their relative importance. One population-based study reported the following results [<a href="#rid14">14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Male factor (hypogonadism, post-testicular defects, seminiferous tubule dysfunction) – 26 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Ovulatory dysfunction – 21 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Tubal damage – 14 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Endometriosis – 6 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Coital problems – 6 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Cervical factor – 3 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Unexplained – 28 percent</p><p></p><p>Of note, the total in the above study for all causes of infertility is greater than 100 percent because some couples had more than one problem. The frequency of these factors in infertility is similar whether infertility is primary or secondary, and has not changed significantly over the past 25 years in developed countries [<a href="#rid15">15</a>].</p><p>These causes are discussed in detail separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5408.html" rel="external">"Female infertility: Causes"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7473.html" rel="external">"Causes of male infertility"</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h1">WHO SHOULD PERFORM THE INFERTILITY EVALUATION?</span><span class="headingEndMark"> — </span>Infertility evaluations should be directed by fertility specialists or physicians with experience in the evaluation and treatment of infertility, where available. In many cases, it is appropriate for primary care physicians to initiate portions of the infertility evaluation. In general, obstetricians-gynecologists should be able to perform the basics of the fertility work-up. In observational studies, however, providers with expertise in diagnosis and treatment of infertility tended to provide more cost-effective care than less experienced primary care providers, and were generally more able to fulfill the emotional, informational, and diagnostic needs of their patients [<a href="#rid16">16-21</a>]. Although a less experienced provider may initiate the infertility evaluation, couples with abnormal test results should be referred to a specialist.</p><p>Specific guidelines for practices offering assisted reproductive technologies have been developed by the American Society for Reproductive Medicine [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H8"><span class="h1">TIMING OF INFERTILITY EVALUATION</span><span class="headingEndMark"> — </span>The general consensus among infertility experts is that infertility evaluation should be undertaken for couples who have not been able to conceive after 12 months of unprotected and frequent intercourse, but earlier evaluation should be undertaken based on medical history and physical findings, and in women over 35 years of age (<a class="graphic graphic_table graphicRef70415" href="/d/graphic/70415.html" rel="external">table 1</a>) [<a href="#rid23">23</a>]. Some authorities have proposed initiating an infertility work-up after six months of fertility-oriented intercourse without conception since prospective cohort studies have shown that a significant decline in fecundity occurs by this time [<a href="#rid4">4,7,24</a>].</p><p>The timing of initial evaluation of infertility depends upon the age of the female partner, as well as the couple's historical risk factors (<a class="graphic graphic_table graphicRef50278" href="/d/graphic/50278.html" rel="external">table 2</a>). Women experience a decline in fecundity as the ovary ages, especially after age 30 [<a href="#rid25">25</a>]. Significantly delaying the evaluation and treatment of an infertile woman in her mid-thirties may diminish the success rate once therapy is initiated. For these reasons, in women between 35 and 40 years of age, we initiate the infertility evaluation after six months of frequent unprotected intercourse without conception and we initiate the evaluation after less than six months in women over 40 years of age. The American College of Obstetricians and Gynecologists (ACOG) and the American Society for Reproductive Medicine (ASRM) recommend that women older than 35 years receive an expedited infertility evaluation and undergo treatment after 6 months of failed attempts to conceive or earlier, if clinically indicated [<a href="#rid23">23</a>].</p><p>Evaluation is also initiated promptly if the female partner has a history of risk factors for premature ovarian failure (previous extensive ovarian surgery, exposure to cytotoxic drugs or pelvic radiation therapy, autoimmune disease, smoking, strong family history of early menopause/premature ovarian failure), advanced stage endometriosis, or known or suspected uterine/tubal disease [<a href="#rid26">26</a>]. Male factors can also be indications for initiating early evaluation of the male partner. These factors include a history of testicular trauma requiring treatment, adult mumps, impotence or other sexual dysfunction, chemotherapy and/or radiation, or a history of subfertility with another partner.</p><p>For younger couples without risk factors who present with fewer than 12 months of attempted conception, we suggest focusing the initial intervention on teaching timed intercourse, often with the aid of a urinary ovulation predictor kit, and advising that they wait at least 12 months before initiating the infertility evaluation. This recommendation may be modified to fit the specific circumstances of the couple.</p><p>In addition, we recommend changes in lifestyle factors that may improve fertility, including achieving an ideal body mass index, cessation of smoking, and limiting exposure to alcohol. As discussed above, evaluation is initiated sooner if the female partner has a history of oligomenorrhea/amenorrhea, chemotherapy and/or radiation, or endometriosis, known or suspected tubal disease, or if male risk factors are present. (See  <a class="medical medical_review" href="/d/html/5411.html" rel="external">"Natural fertility and impact of lifestyle factors"</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">INFERTILITY EVALUATION</span><span class="headingEndMark"> — </span>The recognition, evaluation, and treatment of infertility are stressful for most couples. The clinician should not ignore the couple's emotional state, which may include depression, anger, anxiety, and marital discord. (See  <a class="medical medical_review" href="/d/html/4859.html" rel="external">"Psychological stress and infertility"</a>.)</p><p>It is important to remember that the couple may have multiple factors contributing to their infertility; therefore, a complete initial diagnostic evaluation, including a complete history and physical examination, should be performed. This will detect the most common causes of infertility, if present. Evaluation of both partners is performed concurrently [<a href="#rid26">26</a>]. The same approach is used for both primary and secondary infertility.</p><p>The following tests are useful in most couples with infertility:</p><p class="bulletIndent1"><span class="glyph">●</span>Semen analysis to assess male factors.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Menstrual history, assessment of luteinizing hormone surge in urine prior to ovulation, and/or luteal phase progesterone level to assess ovulatory function.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hysterosalpingogram or sonohysterogram with a test of tubal patency such as hysterosalpingo-contrast-sonography to assess tubal patency and the uterine cavity.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Assessment of ovarian reserve with day 3 serum follicle-stimulating hormone and estradiol levels, anti-müllerian hormone, and/or antral follicle count.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thyroid-stimulating hormone.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prolactin</p><p></p><p>In select couples, the following additional tests may be warranted:</p><p class="bulletIndent1"><span class="glyph">●</span>Pelvic ultrasound to assess for uterine myomas and ovarian cysts.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laparoscopy to identify endometriosis or other pelvic pathology.</p><p></p><p>A detailed description of the approach to evaluation of the male and female partners can be found separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5445.html" rel="external">"Female infertility: Evaluation"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7453.html" rel="external">"Approach to the male with infertility"</a>.)</p><p></p><p class="headingAnchor" id="H10"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Once the cause of infertility is identified, therapy aimed at correcting reversible etiologies and overcoming irreversible factors can be implemented. The couple is also counseled on lifestyle modifications to improve fertility, such as smoking cessation, reducing excessive caffeine and alcohol consumption, and appropriate timing and frequency of coitus (every one to two days around the expected time of ovulation or according to an ovulation predictor kit). (See  <a class="medical medical_review" href="/d/html/5411.html" rel="external">"Natural fertility and impact of lifestyle factors"</a>.)</p><p>Therapeutic interventions for treatment of male and female infertility may involve drug therapy, surgery, and/or procedures such as intrauterine insemination or in vitro fertilization. Further research on causes of infertility and therapeutic modalities is needed to improve the overall success of infertility treatment. Reducing the cost of therapy, the risk of multiple gestation, and complications such as ovarian hyperstimulation will improve patient acceptance of, and the safety of, infertility therapy.</p><p>The only absolute contraindications to infertility therapy are contraindication to pregnancy and contraindication to use of the drugs or surgery used to enhance fertility. The ethics of restricting infertility therapy for other reasons, such as parental child-rearing ability, severe obesity, lifestyle issues (tobacco smoking, alcohol consumption), are controversial and beyond the scope of this review [<a href="#rid27">27-29</a>]. The parent's marital status, sexual orientation, and HIV status should not be used to deny infertility treatment [<a href="#rid30">30,31</a>].</p><p>Approaches to treatment of the male and female partners are described in detail separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5448.html" rel="external">"Female infertility: Treatments"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7452.html" rel="external">"Treatments for male infertility"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/7410.html" rel="external">"Unexplained infertility"</a>.)</p><p></p><p class="headingAnchor" id="H24371980"><span class="h1">PREGNANCY OUTCOME</span><span class="headingEndMark"> — </span>Women who use infertility therapies (in vitro fertilization [IVF] or non-IVF) appear to have a small but statistically significant increase in risk of some pregnancy complications, such as low birth weight, preterm birth, and severe maternal morbidity [<a href="#rid32">32-37</a>]. Compared with the general population, however, an increased risk of preterm birth and low birth weight has also been observed among untreated subfertile women who conceived naturally [<a href="#rid35">35,38</a>]. The relationship between the various causes of infertility, types of infertility treatment, and pregnancy outcomes requires further study to determine the specific risks and the mechanisms involved. (See  <a class="medical medical_review" href="/d/html/6788.html" rel="external">"Assisted reproductive technology: Pregnancy and maternal outcomes"</a>.)</p><p class="headingAnchor" id="H447678161"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114191.html" rel="external">"Society guideline links: Female infertility"</a>.)</p><p class="headingAnchor" id="H11"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/d/html/15426.html" rel="external">"Patient education: Infertility in couples (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/d/html/2175.html" rel="external">"Patient education: Evaluation of infertility in couples (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H12"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Definition and timing of evaluation</strong> – Infertility is classically defined as the failure of a couple to conceive; the time frame varies with the age of the female partner (<a class="graphic graphic_table graphicRef70415" href="/d/graphic/70415.html" rel="external">table 1</a>). Fecundability is the probability of achieving a pregnancy in one menstrual cycle. (See <a class="local">'Description and related terms'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For persons under age 35 years, infertility is the lack of conception after 12 months of regular and appropriately timed intercourse without use of contraception. (See <a class="local">'Timing of infertility evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For persons age 35 years and older, infertility is the lack of conception after six months of regular and appropriately timed intercourse without use of contraception. (See <a class="local">'Timing of infertility evaluation'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Earlier evaluation may be justified based on medical history (eg, history of chemotherapy or pelvic radiation) and physical findings (eg, pelvic mass). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Fecundability</strong> – While 80 to 90 percent of couples (combined data, all age groups) will conceive within 12 months of attempting pregnancy, fecundability progressively decreases over time. (See <a class="local">'Normal fertility'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common identifiable causes</strong> – Infertility can be due to female factors, male factors, or factors contributed by both partners. (See <a class="local">'Causes of infertility'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Female-specific factors include ovulatory dysfunction, tubal damage, endometriosis, and cervical factor.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Male-specific factors include hypogonadism, post-testicular defects, and seminiferous tubule dysfunction.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other causes – In some cases, infertility is due to coital problems or is unexplained. (See  <a class="medical medical_review" href="/d/html/7410.html" rel="external">"Unexplained infertility"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Components of the basic infertility evaluation include history (<a class="graphic graphic_table graphicRef50278" href="/d/graphic/50278.html" rel="external">table 2</a>) and physical examination, semen analysis, menstrual history, laboratory tests, and assessment of the fallopian tubes and uterus using hysterosalpingography, hysteroscopy, ultrasonography, and/or laparoscopy. Common laboratory tests include assessment of ovarian reserve (may include day 3 serum follicle-stimulating hormone and estradiol levels, anti-müllerian hormone, and/or antral follicle count) and thyroid-stimulating hormone level. (See <a class="local">'Infertility evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – If a cause of infertility is identified, therapy aimed at correcting reversible etiologies and overcoming irreversible factors can be implemented. Therapeutic interventions for treatment of male and female infertility may involve drug therapy, surgery, and/or procedures such as intrauterine insemination or in vitro fertilization. (See <a class="local">'Treatment'</a> above.)</p><p></p><p class="bulletIndent1">Discussion of targeted treatments, as well as discussion of unexplained infertility, are described in detail separately.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/5448.html" rel="external">"Female infertility: Treatments"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/7452.html" rel="external">"Treatments for male infertility"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>(See  <a class="medical medical_review" href="/d/html/7410.html" rel="external">"Unexplained infertility"</a>.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">Definition of Infertility: A Committee Opinion (2023). Practice Committee of the American Society for Reproductive Medicine. American Society for Reproductive Medicine. October 2023. https://www.asrm.org/practice-guidance/practice-committee-documents/denitions-of-infertility/?_t_tags=siteid%3a01216f06-3dc9-4ac9-96da-555740dd020c%2clanguage%3aen&amp;_t_hit.id=ASRM_Models_Pages_ContentPage/_1bd481cd-5547-4afe-a440-d6651a17391f_en&amp;_t_hit.pos=1 (Accessed on October 18, 2023).</li><li><a class="nounderline abstract_t">Zegers-Hochschild F, Adamson GD, Dyer S, et al. The International Glossary on Infertility and Fertility Care, 2017. Fertil Steril 2017; 108:393.</a></li><li><a class="nounderline abstract_t">Joffe M, Key J, Best N, et al. Studying time to pregnancy by use of a retrospective design. Am J Epidemiol 2005; 162:115.</a></li><li><a class="nounderline abstract_t">Gnoth C, Godehardt D, Godehardt E, et al. Time to pregnancy: results of the German prospective study and impact on the management of infertility. Hum Reprod 2003; 18:1959.</a></li><li><a class="nounderline abstract_t">Zinaman MJ, Clegg ED, Brown CC, et al. Estimates of human fertility and pregnancy loss. Fertil Steril 1996; 65:503.</a></li><li><a class="nounderline abstract_t">GUTTMACHER AF. Factors affecting normal expectancy of conception. J Am Med Assoc 1956; 161:855.</a></li><li><a class="nounderline abstract_t">Wang X, Chen C, Wang L, et al. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 2003; 79:577.</a></li><li><a class="nounderline abstract_t">Slama R, Hansen OK, Ducot B, et al. Estimation of the frequency of involuntary infertility on a nation-wide basis. Hum Reprod 2012; 27:1489.</a></li><li class="breakAll">Infertility Prevalence Estimates, 1990-2021. World Health Organzation. April 2023. https://www.who.int/publications/i/item/978920068315 (Accessed on April 05, 2023).</li><li><a class="nounderline abstract_t">Sun H, Gong TT, Jiang YT, et al. Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from a global burden of disease study, 2017. Aging (Albany NY) 2019; 11:10952.</a></li><li><a class="nounderline abstract_t">Snow M, Vranich TM, Perin J, Trent M. Estimates of infertility in the United States: 1995-2019. Fertil Steril 2022; 118:560.</a></li><li><a class="nounderline abstract_t">Willis MD, Orta OR, Ncube C, et al. Association Between Neighborhood Disadvantage and Fertility Among Pregnancy Planners in the US. JAMA Netw Open 2022; 5:e2218738.</a></li><li class="breakAll">WHO Technical Report Series. Recent Advances in Medically Assisted Conception Number 820, 1992, pp 1-111.</li><li><a class="nounderline abstract_t">Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291:1693.</a></li><li><a class="nounderline abstract_t">Bhattacharya S, Porter M, Amalraj E, et al. The epidemiology of infertility in the North East of Scotland. Hum Reprod 2009; 24:3096.</a></li><li><a class="nounderline abstract_t">Kerr J, Brown C, Balen AH. The experiences of couples who have had infertility treatment in the United Kingdom: results of a survey performed in 1997. Hum Reprod 1999; 14:934.</a></li><li><a class="nounderline abstract_t">VanderLaan B, Karande V, Krohm C, et al. Cost considerations with infertility therapy: outcome and cost comparison between health maintenance organization and preferred provider organization care based on physician and facility cost. Hum Reprod 1998; 13:1200.</a></li><li><a class="nounderline abstract_t">Halman LJ, Abbey A, Andrews FM. Why are couples satisfied with infertility treatment? Fertil Steril 1993; 59:1046.</a></li><li><a class="nounderline abstract_t">Ceballo R, Abbey A, Schooler D. Perceptions of women's infertility: what do physicians see? Fertil Steril 2010; 93:1066.</a></li><li><a class="nounderline abstract_t">Wilkes S, Hall N, Crosland A, et al. General practitioners' perceptions and attitudes to infertility management in primary care: focus group study. J Eval Clin Pract 2007; 13:358.</a></li><li><a class="nounderline abstract_t">Wilkes S, Hall N, Crosland A, et al. Patient experience of infertility management in primary care: an in-depth interview study. Fam Pract 2009; 26:309.</a></li><li><a class="nounderline abstract_t">Practice Committee of the American Society for Reproductive Medicine, Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee of the Society of Reproductive Biology and Technology. Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion. Fertil Steril 2014; 102:682.</a></li><li><a class="nounderline abstract_t">American College of Obstetricians and Gynecologists Committee on Gynecologic Practice and Practice Committee. Female age-related fertility decline. Committee Opinion No. 589. Fertil Steril 2014; 101:633. Reaffirmed 2022.</a></li><li><a class="nounderline abstract_t">Brosens I, Gordts S, Valkenburg M, et al. Investigation of the infertile couple: when is the appropriate time to explore female infertility? Hum Reprod 2004; 19:1689.</a></li><li><a class="nounderline abstract_t">Schwartz D, Mayaux MJ. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS. N Engl J Med 1982; 306:404.</a></li><li><a class="nounderline abstract_t">Practice Committee of American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertil Steril 2012; 98:302.</a></li><li><a class="nounderline abstract_t">ESHRE Task Force on Ethics and Law, including, Dondorp W, de Wert G, et al. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010; 25:578.</a></li><li><a class="nounderline abstract_t">Ethics Committee of American Society for Reproductive Medicine. Child-rearing ability and the provision of fertility services: a committee opinion. Fertil Steril 2013; 100:50.</a></li><li><a class="nounderline abstract_t">Pandey S, Maheshwari A, Bhattacharya S. Should access to fertility treatment be determined by female body mass index? Hum Reprod 2010; 25:815.</a></li><li><a class="nounderline abstract_t">Ethics Committee of the American Society for Reproductive Medicine. Human immunodeficiency virus and infertility treatment. Fertil Steril 2004; 82 Suppl 1:S228.</a></li><li><a class="nounderline abstract_t">Ethics Committee of American Society for Reproductive Medicine. Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion. Fertil Steril 2013; 100:1524.</a></li><li><a class="nounderline abstract_t">Welmerink DB, Voigt LF, Daling JR, Mueller BA. Infertility treatment use in relation to selected adverse birth outcomes. Fertil Steril 2010; 94:2580.</a></li><li><a class="nounderline abstract_t">Jaques AM, Amor DJ, Baker HW, et al. Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies. Fertil Steril 2010; 94:2674.</a></li><li><a class="nounderline abstract_t">Messerlian C, Platt RW, Tan SL, et al. Low-technology assisted reproduction and the risk of preterm birth in a hospital-based cohort. Fertil Steril 2015; 103:81.</a></li><li><a class="nounderline abstract_t">Declercq E, Luke B, Belanoff C, et al. Perinatal outcomes associated with assisted reproductive technology: the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). Fertil Steril 2015; 103:888.</a></li><li><a class="nounderline abstract_t">Martin AS, Monsour M, Kissin DM, et al. Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012. Obstet Gynecol 2016; 127:59.</a></li><li><a class="nounderline abstract_t">Murugappan G, Li S, Lathi RB, et al. Increased risk of severe maternal morbidity among infertile women: analysis of US claims data. Am J Obstet Gynecol 2020; 223:404.e1.</a></li><li><a class="nounderline abstract_t">Wise LA, Mikkelsen EM, Sørensen HT, et al. Prospective study of time to pregnancy and adverse birth outcomes. Fertil Steril 2015; 103:1065.</a></li></ol></div><div id="topicVersionRevision">Topic 7396 Version 44.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://www.asrm.org/practice-guidance/practice-committee-documents/denitions-of-infertility/?_t_tags=siteid%3a01216f06-3dc9-4ac9-96da-555740dd020c%2clanguage%3aen&amp;_t_hit.id=ASRM_Models_Pages_ContentPage/_1bd481cd-5547-4afe-a440-d6651a17391f_en&amp;_t_hit.pos=1" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Definition of Infertility: A Committee Opinion (2023). Practice Committee of the American Society for Reproductive Medicine. American Society for Reproductive Medicine. October 2023. https://www.asrm.org/practice-guidance/practice-committee-documents/denitions-of-infertility/?_t_tags=siteid%3a01216f06-3dc9-4ac9-96da-555740dd020c%2clanguage%3aen&amp;_t_hit.id=ASRM_Models_Pages_ContentPage/_1bd481cd-5547-4afe-a440-d6651a17391f_en&amp;_t_hit.pos=1 (Accessed on October 18, 2023).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28760517" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The International Glossary on Infertility and Fertility Care, 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15972942" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Studying time to pregnancy by use of a retrospective design.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12923157" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Time to pregnancy: results of the German prospective study and impact on the management of infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8774277" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Estimates of human fertility and pregnancy loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13319020" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Factors affecting normal expectancy of conception.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12620443" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22416008" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Estimation of the frequency of involuntary infertility on a nation-wide basis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22416008" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Estimation of the frequency of involuntary infertility on a nation-wide basis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31790362" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Global, regional, and national prevalence and disability-adjusted life-years for infertility in 195 countries and territories, 1990-2017: results from a global burden of disease study, 2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35710598" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Estimates of infertility in the United States: 1995-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35771576" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Association Between Neighborhood Disadvantage and Fertility Among Pregnancy Planners in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35771576" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Association Between Neighborhood Disadvantage and Fertility Among Pregnancy Planners in the US.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3935248" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Population study of causes, treatment, and outcome of infertility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19684046" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : The epidemiology of infertility in the North East of Scotland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10221223" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The experiences of couples who have had infertility treatment in the United Kingdom: results of a survey performed in 1997.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9647547" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cost considerations with infertility therapy: outcome and cost comparison between health maintenance organization and preferred provider organization care based on physician and facility cost.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8486172" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Why are couples satisfied with infertility treatment?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19171334" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Perceptions of women's infertility: what do physicians see?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17518799" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : General practitioners' perceptions and attitudes to infertility management in primary care: focus group study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19535736" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Patient experience of infertility management in primary care: an in-depth interview study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24954775" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Revised minimum standards for practices offering assisted reproductive technologies: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24559617" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Female age-related fertility decline. Committee Opinion No. 589.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15262891" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Investigation of the infertile couple: when is the appropriate time to explore female infertility?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7057832" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. Federation CECOS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22698637" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Diagnostic evaluation of the infertile female: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20085914" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Lifestyle-related factors and access to medically assisted reproduction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23481278" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Child-rearing ability and the provision of fertility services: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20129994" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Should access to fertility treatment be determined by female body mass index?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15363737" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Human immunodeficiency virus and infertility treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24094420" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Access to fertility treatment by gays, lesbians, and unmarried persons: a committee opinion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20434152" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Infertility treatment use in relation to selected adverse birth outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20381039" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25456793" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Low-technology assisted reproduction and the risk of preterm birth in a hospital-based cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25660721" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Perinatal outcomes associated with assisted reproductive technology: the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26646124" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Trends in Severe Maternal Morbidity After Assisted Reproductive Technology in the United States, 2008-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32112734" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Increased risk of severe maternal morbidity among infertile women: analysis of US claims data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25707334" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Prospective study of time to pregnancy and adverse birth outcomes.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
